{"id":7695,"date":"2022-02-15T09:37:39","date_gmt":"2022-02-15T08:37:39","guid":{"rendered":"https:\/\/irlab.se\/?page_id=7695"},"modified":"2026-01-13T14:27:08","modified_gmt":"2026-01-13T13:27:08","slug":"startsida","status":"publish","type":"page","link":"https:\/\/irlab.se\/sv\/","title":{"rendered":"Startsida"},"content":{"rendered":"\n
\"\"<\/span>
\n
\n
\n
<\/div>\n\n\n\n

Att f\u00f6r\u00e4ndra livet f\u00f6r personer som lever med Parkinson och andra CNS sjukdomar<\/h1>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\"\"<\/span>
\n
<\/div>\n\n\n\n

Att f\u00f6r\u00e4ndra livet f\u00f6r personer som lever med Parkinson och andra CNS sjukdomar<\/h1>\n<\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\n\n
\n SENASTE PRESSMEDDELANDET<\/span>\n <\/div>\n \n
\n\n \n 3 SEPTEMBER 2026 \/ REGULATORISK<\/span>\n <\/span>\n\n

IRLAB:s vd avser att l\u00e4mna sin position under det f\u00f6rsta kvartalet 2027<\/h3>\n\n

G\u00f6teborg, 3 september 2026 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett f\u00f6retag som uppt\u00e4cker och utvecklar nya behandlingar f\u00f6r Parkinsons sjukdom, meddelar idag att Kristina Torfg\u00e5rd har informerat styrelsen om att hon \u00f6nskar l\u00e4mna sin position som vd. Hon kommer att kvarst\u00e5 i vd-rollen till f\u00f6rsta kvartalet 2027, vilket skapar goda f\u00f6ruts\u00e4ttningar f\u00f6r en smidig \u00f6verg\u00e5ng till hennes eftertr\u00e4dare. Styrelsen kommer omedelbart att inleda arbetet med att s\u00e4kerst\u00e4lla ett v\u00e4l strukturerat ledarskifte.<\/p>\n \n\n L\u00e4s mer ><\/a>\n <\/div>\n \n \n \n <\/div>\n<\/div><\/div>\n\n\n\n

\n
\n
\n
\n
IRLAB A<\/div>\n
1.848<\/div>\n
SEK<\/div>\n\n <\/div>\n\n
\n
\n
\n
TODAY<\/div>\n
-2.63 %<\/div>\n <\/div>\n\n
\n
TODAY SEK<\/div>\n
-0.05 SEK<\/div>\n\n <\/div>\n\n
\n
16:00:00<\/div>\n
2026-09-11<\/div>\n <\/div>\n <\/div>\n Mer om aktien ><\/a>\n <\/div>\n\n <\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

ISP – IRLAB:s unika och egenutvecklade teknikplattform<\/h2>\n\n\n\n

IRLAB:s unika och resurseffektiva forskningsmetod kallad Integrative Screening Process (ISP) genererar bolagets l\u00e4kemedelskandidater. Denna egenutvecklade plattform \u00e4r byggd ett p\u00e5 systembiologiskt syns\u00e4tt med en omfattande, standardiserad, och v\u00e4rldsunik databas \u00f6ver CNS-substanser och klasser som samlats in under 25 \u00e5rs forskning.<\/p>\n\n\n\n

\n
L\u00e4s mer om ISP ><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/span>
\n
\n
\n

IRLAB:s TV\u00c5 L\u00c4KEMEDELSKANDIDATER I KLINISK FAS II<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

Mesdopetam (IRL790)<\/h2>\n\n\n\n

Utvecklas f\u00f6r att behandla levodopa-inducerad dyskinesi (LIDs), dvs ofrivilliga \u00f6verr\u00f6relser som uppkommer efter l\u00e5ngtidsbehandling med levodopa vid Parkinsons sjukdom.<\/p>\n\n\n\n

\n
L\u00e4s mer om mesdopetam ><\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

Pirepemat (IRL752)<\/h2>\n\n\n\n

Utvecklas f\u00f6r att behandla och minska risken f\u00f6r fall och fallolyckor vid Parkinsons sjukdom.<\/p>\n\n\n\n

\n
L\u00e4s mer om pirepemat ><\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\n
\n SENASTE PRESENTATIONEN <\/div>\n \n
\n \n\t\t\t\t\t\t\t\t\t18 JUNI 2026 \t\t\t\t\t\t\t\t<\/span>\n

Intervju med VD Kristina Torfg\u00e5rd och CFO Gustaf Alb\u00e8rt hos Redeye<\/h3>\n\n

Redeye intervjuade VD Kristina Torfg\u00e5rd och CFO Gustaf Alb\u00e8rt om IRLAB:s annonserade f\u00f6retr\u00e4desemission och bolagets fokus fram\u00e5t. Publicerad den 16 juni 2026. Watch the video on Vimeo<\/p>\n\n L\u00e4s mer ><\/a>\n <\/div>\n\n \n\n \n <\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

ISP – IRLAB:s unika och egenutvecklade teknikplattform IRLAB:s unika och resurseffektiva forskningsmetod kallad Integrative Screening Process (ISP) genererar bolagets l\u00e4kemedelskandidater. Denna egenutvecklade plattform \u00e4r byggd ett p\u00e5 systembiologiskt syns\u00e4tt med en omfattande, standardiserad, och v\u00e4rldsunik databas \u00f6ver CNS-substanser och klasser som samlats in under 25 \u00e5rs forskning.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page__homepage.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-7695","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nStartsida - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Startsida - IRLAB\" \/>\n<meta property=\"og:description\" content=\"ISP – IRLAB:s unika och egenutvecklade teknikplattform IRLAB:s unika och resurseffektiva forskningsmetod kallad Integrative Screening Process (ISP) genererar bolagets l\u00e4kemedelskandidater. Denna egenutvecklade plattform \u00e4r byggd ett p\u00e5 systembiologiskt syns\u00e4tt med en omfattande, standardiserad, och v\u00e4rldsunik databas \u00f6ver CNS-substanser och klasser som samlats in under 25 \u00e5rs forskning.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-13T13:27:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web-1024x495.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"495\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/\",\"url\":\"https:\\\/\\\/irlab.se\\\/sv\\\/\",\"name\":\"Startsida - IRLAB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/irlab.se\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/irlab.se\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Irlab_start_2_web.png\",\"datePublished\":\"2022-02-15T08:37:39+00:00\",\"dateModified\":\"2026-01-13T13:27:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/irlab.se\\\/sv\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/#primaryimage\",\"url\":\"https:\\\/\\\/irlab.se\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Irlab_start_2_web.png\",\"contentUrl\":\"https:\\\/\\\/irlab.se\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Irlab_start_2_web.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/irlab.se\\\/sv\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/irlab.se\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Startsida\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/irlab.se\\\/#website\",\"url\":\"https:\\\/\\\/irlab.se\\\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/irlab.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Startsida - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/","og_locale":"sv_SE","og_type":"article","og_title":"Startsida - IRLAB","og_description":"ISP – IRLAB:s unika och egenutvecklade teknikplattform IRLAB:s unika och resurseffektiva forskningsmetod kallad Integrative Screening Process (ISP) genererar bolagets l\u00e4kemedelskandidater. Denna egenutvecklade plattform \u00e4r byggd ett p\u00e5 systembiologiskt syns\u00e4tt med en omfattande, standardiserad, och v\u00e4rldsunik databas \u00f6ver CNS-substanser och klasser som samlats in under 25 \u00e5rs forskning.","og_url":"https:\/\/irlab.se\/sv\/","og_site_name":"IRLAB","article_modified_time":"2026-01-13T13:27:08+00:00","og_image":[{"width":1024,"height":495,"url":"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web-1024x495.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/","url":"https:\/\/irlab.se\/sv\/","name":"Startsida - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/irlab.se\/sv\/#primaryimage"},"image":{"@id":"https:\/\/irlab.se\/sv\/#primaryimage"},"thumbnailUrl":"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png","datePublished":"2022-02-15T08:37:39+00:00","dateModified":"2026-01-13T13:27:08+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/irlab.se\/sv\/#primaryimage","url":"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png","contentUrl":"https:\/\/irlab.se\/wp-content\/uploads\/2024\/10\/Irlab_start_2_web.png"},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Startsida"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/7695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=7695"}],"version-history":[{"count":79,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/7695\/revisions"}],"predecessor-version":[{"id":12779,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/pages\/7695\/revisions\/12779"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=7695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}